| 1 |
Quaresima S, Melandro F, Giovanardi F, Shah K, De Peppo V, Mennini G, Ghinolfi D, Limkemann A, Pawlik TM, Lai Q. New Insights in the Setting of Transplant Oncology. Medicina 2023;59:568. [DOI: 10.3390/medicina59030568] [Reference Citation Analysis]
|
| 2 |
Giovinazzo F, Pascale MM, Cardella F, Picarelli M, Molica S, Zotta F, Martullo A, Clarke G, Frongillo F, Grieco A, Agnes S. Current Perspectives in Liver Transplantation for Perihilar Cholangiocarcinoma. Current Oncology 2023;30:2942-2953. [DOI: 10.3390/curroncol30030225] [Reference Citation Analysis]
|
| 3 |
Cremen S, Kelly ME, Gallagher TK. The role of neo-adjuvant therapy in cholangiocarcinoma: A systematic review. Front Oncol 2022;12:975136. [PMID: 36568243 DOI: 10.3389/fonc.2022.975136] [Reference Citation Analysis]
|
| 4 |
Manzia TM, Parente A, Lenci I, Sensi B, Milana M, Gazia C, Signorello A, Angelico R, Grassi G, Tisone G, Baiocchi L. Moving forward in the treatment of cholangiocarcinoma. World J Gastrointest Oncol 2021; 13(12): 1939-1955 [DOI: 10.4251/wjgo.v13.i12.1939] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Zhang Q, Liu X, Wei S, Zhang L, Tian Y, Gao Z, Jin M, Yan S. Lenvatinib Plus PD-1 Inhibitors as First-Line Treatment in Patients With Unresectable Biliary Tract Cancer: A Single-Arm, Open-Label, Phase II Study. Front Oncol 2021;11:751391. [PMID: 34900698 DOI: 10.3389/fonc.2021.751391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Anichini G, Carrassa L, Stecca B, Marra F, Raggi C. The Role of the Hedgehog Pathway in Cholangiocarcinoma. Cancers (Basel) 2021;13:4774. [PMID: 34638259 DOI: 10.3390/cancers13194774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 7 |
Ziogas IA, Rauf MA, Matsuoka LK, Izzy M, Rega SA, Feurer ID, Alexopoulos SP. Liver Transplantation for Cholangiocarcinoma: Charting a Path With Lessons Learned From Center Experience. Transplant Direct 2021;7:e686. [PMID: 34549084 DOI: 10.1097/TXD.0000000000001133] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 8 |
Angelico R, Sensi B, Parente A, Siragusa L, Gazia C, Tisone G, Manzia TM. Vascular Involvements in Cholangiocarcinoma: Tips and Tricks. Cancers (Basel) 2021;13:3735. [PMID: 34359635 DOI: 10.3390/cancers13153735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Lauterio A, De Carlis R, Centonze L, Buscemi V, Incarbone N, Vella I, De Carlis L. Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma. Cancers (Basel) 2021;13. [PMID: 34359560 DOI: 10.3390/cancers13153657] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 10 |
Dopazo C, Lladó L, Fondevila C, Macarulla T, Navalpotro B, Ramos E, Fabregat J, Laquente B, Navasa M, Castells L, Bilbao I, García Valdecasas J, Charco R. Applicability and results of liver transplant combined with neoadjuvant chemo-radiotherapy in the treatment of unresectable hilar cholangiocarcinoma. Cirugía Española (English Edition) 2021;99:190-199. [DOI: 10.1016/j.cireng.2021.02.026] [Reference Citation Analysis]
|
| 11 |
Mcmillan RR, Saharia A, Abdelrahim M, Ghobrial RM. New Breakthroughs for Liver Transplantation of Cholangiocarcinoma. Curr Transpl Rep 2021;8:21-7. [DOI: 10.1007/s40472-021-00313-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Cholangiocarcinoma Working Group. Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment. Dig Liver Dis 2020;52:1430-42. [PMID: 32952071 DOI: 10.1016/j.dld.2020.08.030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 13 |
Tan EK, Taner T, Heimbach JK, Gores GJ, Rosen CB. Liver Transplantation for Peri-hilar Cholangiocarcinoma. J Gastrointest Surg 2020;24:2679-85. [PMID: 32671802 DOI: 10.1007/s11605-020-04721-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 14 |
Azad AI, Rosen CB, Taner T, Heimbach JK, Gores GJ. Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver Transplantation.Cancers (Basel). 2020;12. [PMID: 33121179 DOI: 10.3390/cancers12113157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 15 |
Hand F, Hoti E. Surgical Volume Alone Does Not Determine Outcome Following Liver Transplant for Perihilar Cholangiocarcinoma. Ann Surg Oncol 2020;27:930-1. [PMID: 32901313 DOI: 10.1245/s10434-020-09115-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 16 |
Dondossola D, Ghidini M, Grossi F, Rossi G, Foschi D. Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma. World J Gastroenterol 2020; 26(25): 3542-3561 [PMID: 32742125 DOI: 10.3748/wjg.v26.i25.3542] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 17 |
Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Rizvi S, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 2020;17:557-88. [PMID: 32606456 DOI: 10.1038/s41575-020-0310-z] [Cited by in Crossref: 622] [Cited by in F6Publishing: 599] [Article Influence: 207.3] [Reference Citation Analysis]
|
| 18 |
Zamora-Valdes D, Heimbach JK. Liver Transplant for Cholangiocarcinoma. Gastroenterol Clin North Am 2018;47:267-80. [PMID: 29735023 DOI: 10.1016/j.gtc.2018.01.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 19 |
Ethun CG, Lopez-Aguiar AG, Anderson DJ, Adams AB, Fields RC, Doyle MB, Chapman WC, Krasnick BA, Weber SM, Mezrich JD, Salem A, Pawlik TM, Poultsides G, Tran TB, Idrees K, Isom CA, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Cardona K, Maithel SK. Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease. Ann Surg 2018;267:797-805. [PMID: 29064885 DOI: 10.1097/SLA.0000000000002574] [Cited by in Crossref: 101] [Cited by in F6Publishing: 102] [Article Influence: 20.2] [Reference Citation Analysis]
|
| 20 |
Jadlowiec CC, Heimbach JK. Hilar Cholangiocarcinoma: Resection or Transplantation? Curr Surg Rep 2017;5:7. [DOI: 10.1007/s40137-017-0168-3] [Reference Citation Analysis]
|
| 21 |
Jadlowiec CC, Heimbach JK. Looking Forward: Surgical Resection, Liver Transplantation, and Hilar Cholangiocarcinoma. Curr Hepatology Rep 2016;15:317-322. [DOI: 10.1007/s11901-016-0320-z] [Reference Citation Analysis]
|
| 22 |
Arend J, Schütte K, Däberitz T, Bretschneider T, Benedix F, Udelnow A, Wolff S, Bruns CJ. Lebertransplantation bei Malignomen und Vorläufererkrankungen. Onkologe 2016;22:451-460. [DOI: 10.1007/s00761-016-0052-2] [Reference Citation Analysis]
|
